Taro Pharmaceutical Industries Ltd. (TARO) CEO Uday Baldota on Q2 2020 Results - Earnings Call Transcript [Seeking Alpha]
Taro Pharmaceutical Industries Ltd. Ordinary Shares (TARO)
Last taro pharmaceutical industries ltd. ordinary shares earnings: 2/3 05:21 pm
Check Earnings Report
US:NYSE Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=114698&p=irol-irhome
Company Research
Source: Seeking Alpha
Taro Pharmaceutical Industries Ltd. (TARO) CEO Uday Baldota on Q2 2020 Results - Earnings Call Transcript Taro Pharmaceutical Industries Ltd. (NYSE: TARO Company Participants William Coote - Assistant Vice President of Business Finance & Investor relations & Treasurer Dilip Shanghvi - Chairman of the Board of Directors Uday Baldota - Chief Executive Officer Mariano Balaguer - Vice President & Chief Financial Officer Conference Call Participants Edward Marks - H.C. Wainwright Anubhav Aggarwal - Credit Suisse Shyam Srinivasan - man Sachs Sameer Baisiwala - Morgan Stanley Neha Manpuria - JPMorgan Operator Good afternoon, ladies and gentlemen and welcome to the Taro Pharmaceutical's Second Quarter 2019/2020 Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to turn the conference over to
Show less
Read more
Impact Snapshot
Event Time:
TARO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TARO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TARO alerts
High impacting Taro Pharmaceutical Industries Ltd. Ordinary Shares news events
Weekly update
A roundup of the hottest topics
TARO
News
- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.MarketBeat
- TARO PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Taro Pharmaceutical Industries Ltd. - TAROBusiness Wire
- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.MarketBeat
- Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd. [Yahoo! Finance]Yahoo! Finance
- Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.Business Wire
TARO
Earnings
- 1/25/24 - Beat
TARO
Sec Filings
- 4/15/24 - Form SC
- 3/20/24 - Form SC
- 3/11/24 - Form SC
- TARO's page on the SEC website